NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021-Reference-Cited by-同舟云学术

NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021

Published:2020-12 Issue:12 Volume:18 Page:1604-1612
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

von Mehren Margaret¹,Kane John M.²,Bui Marilyn M.³,Choy Edwin⁴,Connelly Mary⁵,Dry Sarah⁶,Ganjoo Kristen N.⁷,George Suzanne⁸,Gonzalez Ricardo J.³,Heslin Martin J.⁹,Homsi Jade¹⁰,Keedy Vicki¹¹,Kelly Ciara M.¹²,Kim Edward¹³,Liebner David⁵,McCarter Martin¹⁴,McGarry Sean V.¹⁵,Meyer Christian¹⁶,Pappo Alberto S.¹⁷,Parkes Amanda M.¹⁸,Paz I. Benjamin¹⁹,Petersen Ivy A.²⁰,Poppe Matthew²¹,Riedel Richard F.²²,Rubin Brian²³,Schuetze Scott²⁴,Shabason Jacob²⁵,Sicklick Jason K.²⁶,Spraker Matthew B.²⁷,Zimel Melissa²⁸,Bergman Mary Anne²⁹,George Giby V.²⁹

Affiliation:

1. 1Fox Chase Cancer Center;

2. 2Roswell Park Comprehensive Cancer Center;

3. 3Moffitt Cancer Center;

4. 4Massachusetts General Hospital Cancer Center;

5. 5The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

6. 6UCLA Jonsson Comprehensive Cancer Center;

7. 7Stanford Cancer Institute;

8. 8Dana-Farber/Brigham and Women’s Cancer Center;

9. 9O'Neal Comprehensive Cancer Center at UAB;

10. 10UT Southwestern Simmons Comprehensive Cancer Center;

11. 11Vanderbilt-Ingram Cancer Center;

12. 12Memorial Sloan Kettering Cancer Center;

13. 13Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

14. 14University of Colorado Cancer Center;

15. 15Fred & Pamela Buffett Cancer Center;

16. 16The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

17. 17St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center;

18. 18University of Wisconsin Carbone Cancer Center;

19. 19City of Hope National Medical Center;

20. 20Mayo Clinic Cancer Center;

21. 21Huntsman Cancer Institute at the University of Utah;

22. 22Duke Cancer Institute;

23. 23Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

24. 24University of Michigan Rogel Cancer Center;

25. 25Abramson Cancer Center at the University of Pennsylvania;

26. 26UC San Diego Moores Cancer Center;

27. 27Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

28. 28UCSF Helen Diller Family Comprehensive Cancer Center; and

29. 29National Comprehensive Cancer Network.

Abstract

The NCCN Guidelines for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with soft tissue sarcomas. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including the development of a separate and distinct guideline for gastrointestinal stromal tumors (GISTs); reconception of the management of desmoid tumors; inclusion of further recommendations for the diagnosis and management of extremity/body wall, head/neck sarcomas, and retroperitoneal sarcomas; modification and addition of systemic therapy regimens for sarcoma subtypes; and revision of the principles of radiation therapy for soft tissue sarcomas.

Publisher

Harborside Press, LLC

Subject

Oncology

Link

https://jnccn.org/downloadpdf/journals/jnccn/18/12/article-p1604.xml

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mitotic rate as a prognostic biomarker after preoperative radiotherapy for high-grade limb/trunk soft tissue sarcoma;Radiotherapy and Oncology;2024-11

2. Evaluating the Alignment of Artificial Intelligence‐Generated Recommendations With Clinical Guidelines Focused on Soft Tissue Tumors;Journal of Surgical Oncology;2024-09-05

3. Gene Mutations in Gastrointestinal Stromal Tumors: Advances in Treatment and Mechanism Research;Global Medical Genetics;2024-08-22

4. Management of subepithelial esophageal tumors;Innovative Surgical Sciences;2024-08-20

5. Real-life experience with sorafenib for advanced and refractory desmoid-type fibromatosis;Acta Oncologica;2024-08-04